| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 |
| filingDate |
2001-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e38b5804ce734ae9b9b56cad432749c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da2752981fee7357b9559d5fc7945757
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6e24f128bd3cd87d39c8d550f9de483 |
| publicationDate |
2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002147150-A1 |
| titleOfInvention |
Sustained-release preparation |
| abstract |
A sustained-release preparation which comprises a physiologically active peptide of general formula n n n wherein n X represents an acyl group; n R 1 , R 2 and R 4 each represents an aromatic cyclic group; n R 3 represents a D-amino acid residue or a group of the formula n n n wherein n R 3 ′ is a heterocyclic group; n R 5 represents a group of the formula —(CH 2 ) n —R 5 ′ wherein n is 2 or 3, and R 5 ′ is an amino group which may optionally be substituted, an aromatic cyclic group or an O-glycosyl group; n R 6 represents a group of the formula —(CH 2 ) n —R 6 ′ wherein n is 2 or 3, and R 6 ′ is an amino group which may optionally be substituted; n R 7 represents a D-amino acid residue or an azaglycyl residue; and n Q represents hydrogen or a lower alkyl group, or a salt thereof and a biodegradable polymer having a terminal carboxyl group. n The sustained-release preparation shows a constant release of the peptide over a long time and is substantially free from an initial burst. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8628802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010203145-A1 |
| priorityDate |
1992-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |